Duality Biotherapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	1,276	1,209	1,131
Short-Term Investments	2,005	188.06	5.26
Trading Asset Securities	99.14	-	-
Cash & Short-Term Investments	3,380	1,397	1,136
Cash Growth	141.97%	22.96%	-
Accounts Receivable	277.92	379.02	100.8
Other Receivables	39.92	70.44	32.55
Receivables	317.84	449.46	133.35
Restricted Cash	49.71	45.16	42.65
Other Current Assets	86.37	18.26	21.75
Total Current Assets	3,834	1,910	1,334
Property, Plant & Equipment	28.68	18.6	17.76
Other Intangible Assets	3.77	46.24	54.25
Other Long-Term Assets	26.28	115.56	94.01
Total Assets	3,893	2,090	1,500
Accounts Payable	761.94	670.91	234.81
Accrued Expenses	60.44	38.97	25.24
Short-Term Debt	141.06	-	-
Current Portion of Leases	4.81	2.99	2.91
Current Income Taxes Payable	2.29	1.72	0.92
Current Unearned Revenue	77.77	90.26	156.13
Other Current Liabilities	3.57	3,067	2,141
Total Current Liabilities	1,052	3,872	2,561
Long-Term Leases	3.91	2.3	2.41
Long-Term Unearned Revenue	240.92	238.25	60.16
Other Long-Term Liabilities	169.53	-	-
Total Liabilities	1,466	4,112	2,624
Common Stock	0.06	0.01	0.01
Additional Paid-In Capital	6,987	-	-
Retained Earnings	-4,750	-2,161	-1,111
Comprehensive Income & Other	189.27	133.26	-19.2
Total Common Equity	2,427	-2,028	-1,130
Shareholders' Equity	2,427	-2,022	-1,124
Total Liabilities & Equity	3,893	2,090	1,500
Total Debt	149.78	5.29	5.32
Net Cash (Debt)	3,230	1,392	1,131
Net Cash Growth	132.13%	23.07%	-
Net Cash Per Share	49.58	173.96	141.35
Filing Date Shares Outstanding	89.42	8	8
Total Common Shares Outstanding	89.42	8	8
Working Capital	2,782	-1,962	-1,227
Book Value Per Share	27.14	-253.46	-141.22
Tangible Book Value	2,423	-2,074	-1,184
Tangible Book Value Per Share	27.10	-259.24	-148.00
Machinery	19.8	10.74	7.61
Construction In Progress	1.3	0.55	0.19
Leasehold Improvements	8.75	6.92	6.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.